Breadcrumb

Multiple sclerosis

Research group

Short description

Multiple sclerosis (MS) is an inflammatory and degenerative disease that damages the central nervous system. Disease activity and treatment effects are usually monitored clinically and by magnetic resonance imaging (MRI). Our previous studies have shown that the concentration of biochemical markers in cerebrospinal fluid and blood can be used for prediction and evaluation of treatment effects. We are now investigating new methods for measuring neurodegeneration such as synthetic MRI (brain volume) and optical coherence tomography (measurement of the retinal nerve fiber layer). We study the dysregulation of the immune system in MS and how pharmacological interventions affect this. Our aim is to find early predictive biomarkers as a basis for therapeutic decisions and to improve the evaluation of treatment effects.

Group members

Principal Investigator

Jan Lycka, professor

Researchers

Markus Axelsson, Associate Professor
Helen Farman, Post Doc
Firoozeh Amirbeagi, Med Dr
Clas Malmeström, Med Dr
Lenka Novakova Nyrén, Med Dr

Doctoral students

Ólöf Eliasdóttir
Igal Rosenstein
Sofia Sandgren

Research nurses

Anne Frandsen Brandt
Lena Silberberg
Stefanie Unger